{"entity":{"type":"insider","cik":"0001610381","url":"/insider/0001610381","json_url":"/insider/0001610381.json","name":"Vivaldi Coelho Rogerio","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2014-07-09","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Vivaldi Coelho Rogerio","source":"filing","n_filings":9,"first_seen":"2014-07-09","last_seen":"2026-07-07"}],"transactions":[{"id":5986807,"accession":"0001628280-26-047507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-047507","line_url":"/filing/0001628280-26-047507#line-1","is_derivative":false,"issuer_cik":"0001610381","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001610381","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":19225.0,"shares_owned_after_display":"19,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-07","scope":"insider"},{"id":5863605,"accession":"0001628280-26-017797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-017797","line_url":"/filing/0001628280-26-017797","is_derivative":false,"issuer_cik":"0001610381","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001610381","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":36.152174,"price_display":"36.15","price_state":"stated","total_value":180760.87,"total_display":"180,760.87","total_whole":"180,761","shares_owned_after":16823.0,"shares_owned_after_display":"16,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-13","scope":"insider","n_lines":2},{"id":8469307,"accession":"0001209191-23-035618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035618","line_url":"/filing/0001209191-23-035618#line-1","is_derivative":false,"issuer_cik":"0001610381","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001610381","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":22.06,"price_display":"22.06","price_state":"stated","total_value":110300.0,"total_display":"110,300.00","total_whole":"110,300","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":3054604,"accession":"0001609351-16-000073","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001609351-16-000073","line_url":"/filing/0001609351-16-000073","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":53.032,"price_display":"53.03","price_state":"stated","total_value":371224.0,"total_display":"371,224.00","total_whole":"371,224","shares_owned_after":20116.0,"shares_owned_after_display":"20,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-15","filed_date":"2016-07-19","scope":"insider","n_lines":2},{"id":2534607,"accession":"0001609351-16-000025","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001609351-16-000025","line_url":"/filing/0001609351-16-000025#line-6","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":48024.0,"total_display":"48,024.00","total_whole":"48,024","shares_owned_after":18716.0,"shares_owned_after_display":"18,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-21","filed_date":"2016-04-22","scope":"insider"},{"id":2534590,"accession":"0001609351-16-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001609351-16-000025","line_url":"/filing/0001609351-16-000025#line-3","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":232116.0,"total_display":"232,116.00","total_whole":"232,116","shares_owned_after":18716.0,"shares_owned_after_display":"18,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-22","scope":"insider"},{"id":8765545,"accession":"0000899243-15-006721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-006721","line_url":"/filing/0000899243-15-006721#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":48.15,"price_display":"48.15","price_state":"stated","total_value":1155600.0,"total_display":"1,155,600.00","total_whole":"1,155,600","shares_owned_after":18716.0,"shares_owned_after_display":"18,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-13","filed_date":"2015-10-14","scope":"insider"},{"id":8590499,"accession":"0000899243-15-006600","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-15-006600","line_url":"/filing/0000899243-15-006600","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41000.0,"shares_display":"41,000","price_per_share":48.84878048780488,"price_display":"48.85","price_state":"stated","total_value":2002800.0,"total_display":"2,002,800.00","total_whole":"2,002,800","shares_owned_after":6383.0,"shares_owned_after_display":"6,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider","n_lines":2},{"id":8572985,"accession":"0001209191-15-010383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-010383","line_url":"/filing/0001209191-15-010383#line-1","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":57500.0,"total_display":"57,500.00","total_whole":"57,500","shares_owned_after":6383.0,"shares_owned_after_display":"6,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":6725843,"accession":"0001104659-14-050845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-050845","line_url":"/filing/0001104659-14-050845#line-1","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001610381","owner_name":"Vivaldi Coelho Rogerio","owner_display_name":"Vivaldi Coelho Rogerio","owner_url":"/insider/0001610381","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41667.0,"shares_display":"41,667","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":250002.0,"total_display":"250,002.00","total_whole":"250,002","shares_owned_after":41667.0,"shares_owned_after_display":"41,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Director","n_filings":3,"first_seen":"2023-06-09","last_seen":"2026-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001609351","name":"Spark Therapeutics, Inc.","url":"/issuer/0001609351","role":"Officer (Chief Commercial Officer)","n_filings":5,"first_seen":"2015-02-06","last_seen":"2016-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001598646","name":"Minerva Neurosciences, Inc.","url":"/issuer/0001598646","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2014-07-09","last_seen":"2014-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001610381","retrieved_at":"2026-08-27T01:05:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}